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1. Introduction 
A number of studies on the mechanism of action 
of bacterial enterotoxins [1,2], prostaglandins [2] 
and the recently discovered gastrointestinal hormone 
vasoactive intestinal polypeptide (VIP)* [3] on 
small intestinal epithelium stress the role of cyclic 
AMP as a regulator of water and electrolyte trans- 
port in this tissue. The function of cyclic GMP in 
the small intestine is however entirely unknown. Its 
level as well as the activity of the particulate form 
of the enzyme guanylate cyclase in rat small intestinal 
epithelium are relatively high as compared to most 
other mammalian tissues [4-7]. The soluble form 
of guanylate cyclase which, at least in rat heart [6] 
and lung [8], clearly differs from the particulate 
enzyme in kinetic and physical properties, is nearly 
absent in small intestinal mucosa [4,6,7]. Our 
previous work [7] showed that the major part of 
the intestinal enzyme activity is associated with the 
microvillous membrane of the brushborder, the 
remaining part being localized in the basal-lateral 
plasma membranes. Accordingly, proliferative crypt 
cells displayed amuch lower guanylate cyclase 
activity than the mature villous cells [7]. Since 
intestinal brushborders: which are easily obtained 
in a relatively pure state, provide one of the richest 
sources of particulate guanylate cyclase in the rat, 
* Abbreviations: Cyclic GMP, cyclic 3', 5'-guanosine mona- 
phosphate. Cyclic AMP, cyclic 3', 5'-adenosine monophos- 
phate. GTP, guanosine 5'-triphosphate. PEP, phosphoenoi- 
pyruvate, tricyclohexylammonium salt.PTH, parathyroid 
hormone. VP, vasopressin. CP, creatinephosphate. 
the kinetic and other properties of this enzyme may be 
measured accurately even in the absence of an 
activating detergent used in other studie s [6,8]. 
In the present investigation some characteristics 
of the brushborder-localized guanylate cyclase are 
compared with those of microsomal enzyme prepa- 
rations from isolated villous and crypt cells, mainly 
representing enzyme bound to basal-lateral p asma 
membranes. A variety of hormones or hormone-like 
agents reported to raise cyclic AMP levels in rat 
small intestine, to elevate cyclic GMP in other tissues 
or to affect intestinal transport functions, were also 
tested for their ability to alter the intestinal guanylate 
cyclase activity in vitro or to regulate cyclic GMP 
levels in isolated villous and crypt cells and mucosal 
scrapings. The apparent insensitivity of the particulate 
enzyme to hormones and the possible function of 
cyclic GMP in the intestinal mucosa re discussed. 
2. Materials and methods 
Upper villous and crypt cells from the whole 
length of rat small intestine were harvested separately 
as described earlier [9,10]. Brushborders Were 
isolated and purified in principle according to Harrison 
and Webster [11] as described before [12]. Micro- 
somal preparations from villous and crypt cells were 
obtained by homogenizing the cells in 0.25 M 
sucrose-1 mM EDTA-1 mM Tris-HC1 (pH=7,6) 
in a tightly fitting Potter-Elvehjem homogenizer, 
followed by differential centrifugation [10]. Mucosal 
scrapings were isolated by rinsing the intestinal 
lumen with icocold saline followed by gently scraping 
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the superficial mucosal layer with a microscope slide. 
The cell sheets were taken up in saline and centrifuged 
for 2 min at 850g. This procedure was repeated twice. 
Brushborders, cell preparations and microsomes were 
taken up in 0.10 M Tris-HC1 (pH=7.6; final protein 
concentration: about 1 mg/ml) and homogenized in
a Potter-Elvehjem homogenizer prior to enzyme assay. 
Assay of guanylate cyclase activity and purification 
of the labeled product were done essentially as before 
[7]. The concentration of free Mn 2÷ was calculated 
from 2+ iMn2÷ 1 [MnGTP2 -] [Mntotal] = t freel + [MnCP-] + 
The stability constant of MnCP- used for calculating 
[MnCP-] was 110 M -1 [13]. Conversion of creatine- 
phosphate during the assay was less than 15 per cent. 
In view of the high binding constants of Mn2+-nucleo- 
side triphosphates [14] it was assumed that all GTP 
was present as the MnGTP 2- complex. Binding of 
Mn 2÷ to cyclic GMP and the possible binding of 
GTP to albumin were neglected. 
Cyclic GMP concentration was measured according 
to Dinnendahl [15], using a cyclic GMP-binding 
protein from lobster tail muscle [16]. Cyclic AMP 
concentration was measured according to Tovey et al. 
[17], using a cyclic AMP-binding protein isolated 
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Fig. 1. Double reciprocal plots of cyclic GMP formation as a function of the MnGTP 2 -concentration measured with the 
brushborder p eparation, v is expressed as nmoles cyclic GMP • min- i . mg- ] protein. Inset: Hill plots. 
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from bovine skeletal muscle [18]. After further 
purification of the cyclic nucleotide samples by 
thinlayer chromatography on silica plates or 
chromatography onDowex 50H+-columns, essentially 
the same results were obtained. 
Protein was determined according to Lowry et al. 
[19], using bovine serum albumin as a standard. 
Biochemicals were usually from Boehringer, 
Mannheim. Radioactive materials were from the 
Radiochemical Centre, Amersham. Arginine-vaso- 
pressin (synthetic, grade IV) was from Sigma, PTH 
(TCA-powder) from Inolex Corp. (Chicago), secretin 
from the Boots Company (Nottingham), concana- 
valin A (3 times crystallized) from Miles Labs., 
insulin (pure) from Boehringer, pentagastrin (Peptavlon) 
from ICI (Maclesfield), bradykinin (synthetic) from 
Sandoz and glucagon from Lilly (Indianapolis). The 
ionophore A-23187 was a gift from the Eli Lilly 
Company; it was dissolved in ethanol prior to use. 
Prostaglandins were gifts from the Unilever Research 
Lab. (Vlaardingen). Purified choleratoxin was kindly 
supplied by Dr R. S. Northrup, SEATO Cholera 
Research Program, and was prepared under contract 
for NIAID by R. A. Finkelstein, Ph.D., the University 
of Texas, Southwestern Medical Sclaool, Dallas, Texas. 
3. Results 
Some kinetic properties of the brushborder- 
bound guanylate cyclase are shown in fig. 1 and 2. 
Lineweaver-Burk plots for different concentrations 
of free Mn 2÷ (fig. 1) showed a positive co-operative 
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Fig.2. Double reciprocal plots of cyclic GMP formation as a function of excess Mn 2 ÷ measured with the brushborder 
preparation, v is expressed asnmoles cyclic GMP • rain- 1 . mg- ~ protein. 
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Fig.3. Double reciprocal plots ot cyclic GMP formation as a function 2 of  MnGTP -concentrations measured with the microsomal 
preparation from upper villous cells, v is expressed as nmoles cyclic GMP • min-~ • rag-1 protein. Inset: Hill plots. 
MnGTP2Z The Hill plot (fig. I, inset) gave a Hill 
coefficient (n) of 1.6. The S0. 5 for MnGTP 2- 
2+ decreased from 0.25 to 0.14 mM when Mnfree was 
changed from 0.3 to 4.0 raM. Double reciprocal 
plots of cyclic GMP formation as a function of 
excess Mn 2÷ at fixed levels of MnGTP 2- gave 
straight lines with a common point of intersection 
(fig.2). The dissociation constant for excess Mn 2÷, 
calculated from the position of this point, was 
2.5 mM. At [MnGTP 2-] > 0.5 mM the slopes of the 
plots approached zero, indicating that at saturating 
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substrate concentrations the guanylate cyclase no 
longer needs excess Mn 2+ for optimum activity. 
The kinetic patterns of particulate guanylate 
cyclase from upper villous cell microsomes, presumably 
only slightly contaminated with brushborder material 
[10], clearly showed ifferent characteristics (figs.3 
and 4)- There was a marked loss of co-operativity 
with respect to MnGTP 2. especially at low 2+ [Mnfree]. 
At 0.3 mM Mn 2+ free the Hill coefficient approached 
1.2 and the value for S0.swas increased (fig.3). Even 
at near saturating concentrations of MnGTP 2- the 
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Fig.4. Double reciprocal plots of cyclic GMP formation as a function of excess Mn ~* measured with the microsomal preparation 
from upper villous cells, v is expressed asnmoles cyclic GMP • min -t •mg -I protein. 
slope of the reciprocal plots of enzyme activity versus 
[Mnl~ee ] did not approach zero. At O.10 mM 
MnGTP 2- the apparent K m for Mn~ e was 2.7 mM 
and decreased to 0.7 mM at 1.0 mM MnGTP 2" (fig.4). 
Guanylate cyclase from crypt microsome~ displayed 
an intermediate ype of kinetic behaviour showing n- 
values for MnGTP2-between 1.3 and 1.4 (results not 
shown). These preparations, however, are seriously 
contaminated with luminal membranes (compare [20] ) 
and thus contain a mixture of guanylate cyclase 
activities localized in basal-lateral membranes and 
partiall); developed microviUi. 
Some regulatory properties of guanylate in vitro 
were tested with homogenates of isolated villous and 
crypt cells, mucosal scrapings, microsomes and brush- 
borders. Activities were measured at 0.1 mM MnGTP 2- 
and 0.3 or 4.0 mM 2+ Mnfree. Table 1 summarizes our 
results with the brushborder preparation. In agree- 
ment with Ishikawa et al. [4] we found that incub- 
ation of the enzyme in the presence of 0.1% Triton 
X-100 gave a two-fold rise in activity. 1.4 mM CaCl2 
2+ slightly inhibited the enzyme at 0.3 mM Mnfree but 
stimulated 1.2 fold at 4 mM 2+ Mnfree. Strong inhibitory 
effects were found with PEP, oxaloacetate and ATP 
or ADP. Similar effects of metabolites have been 
reported earlier for the soluble enzyme from rat lung 
[21 ]. Alloxan, a strong inhibitor of intestinal adenylate 
cyclase (H. R. de Jonge, unpublished results), slightly 
depressed guanylate cyclase activity, possibly due to 
an in vitro oxidation of SH-groups (compare [22]). 
Aminoacids in physiological concentrations had a 
small stimulatory effect (table 1). D-isomers were 
ineffective in this respect. No significant differences 
from control values were obtained by addition of 
NaF, glucose, choleragen, prostaglandin El ,  F2,~ 
and A1, concanavalin A and a number of catechol- 
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Table 1 
Guanylate cyclase activity in brushborder preparations from 
rat small intestinal epithelium 
Agents Cyclic GMP formation at 0.1 mM GTP 
(% of basal rate) 
0.3 mM Mn~;ee 4.0 mM Mn}~ee 
- 100 100 
Triton X-100 (0.1%) 190 210 
NaF (10 mM) 100 I00 
D (+)glucose (1-50 mM) 100 100 
CaC12 (1.4 mM) 71 117 
PEP (1 mM) 74 82 
PEP (10 mM) 56 62 
Oxaloacetate (0.5 mM) 52 61 
ATP (1 mM) 26 29 
ADP (1 mM) 32 36 
D-alanine (1 mM) 100 99 
L-alanine (1 mM) 119 120 
L-aspartate (1mM) 116 114 
L-arginine (1 mM) 118 115 
Glycine (1 mM) 109 110 
Alloxan (5 mM) 70 75 
The following agents, tested in the presence of 1.4 mM CaC12, had no effect as 
compared to CaCI 2 alone: Concanavalin A (0.2-1 uM), choleratoxin (10-100 
t~g/ml), prostaglandin El, A~ and F2a (1-50 uM), the catecholamines adrenalin, 
noradrenalin and serotonin-creatinesulphate (10-100 ~uM), the cholinergic agents 
carbamylcholine, acetylcholine and pilocarpine (0.5-50/~M) and the peptide 
hormones insulin (1-100 t~g/ml), glucagon (1-10 ~M) +_ pentagastrin (10-50 taM), 
VP (4-50 mU/ml), PTH (0.04-2 U/ml) and bradykinin (50 ~M). 
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amines, cholinergic agents and peptide hormones 
specified in the legend of table 1. These agents have 
been reported to alter intestinal transport of water 
and electrolytes (Na +, K+and HCO~ or Ca 2÷) [2,3], 
to stimulate the soluble form of guanylate cyclase 
in liver in vitro (secretin, [23] ) or to raise cyclic 
GMP levels in other tissues (compare [24].). Similar 
negative results were obtained using villous and 
crypt cell homogenates, microsomes or mucosal 
scrapings. Also after addition of Mg 2+ (1 raM) 
or Ca 2÷ (1.4 mM), the insensitivity of the guany- 
late cyclase for these agents was maintained. 
Because in other tissues cyclic GMP levels 
may be raised by hormones that are unable to 
stimulate the guanylate cyclase activity in vitro, 
our studies were extended with measurements of 
cyclic nucleotide levels in isolated villous and 
crypt cells during incubation at 37°C. Because 
hormone action may be disturbed by isolation 
of cells in EDTA-containing media, these studies 
were repeated with mucosal scrapings, isolated in 
saline. 
As shown in table 2, the basal evels of cyclic 
GMP, like the cyclic AMP levels [25], decreased from 
crypt to villous cells. In contrast, the guanylate 
cyclase activity of cell homogenates increased about 
three-fold [7]. This apparent discrepancy may indicate 
a concomitantly raised cyclic GMP degradation rate 
in the villous cells. Moreover the assay conditions 
in vitro (concentrations of substrates and inhibitors) 
may considerably differ from the enzyme environ- 
ment in the intact cells. The cyclic AMP/cyclic GMP 
ratio was relatively low as compared to a number 
of other tissues [4,26]. CaC12 (1.4 raM) alone caused 
a slight but statistically insignificant depression of 
basal cyclic GMP levels. Also the ionophore A-23187, 
known to mimic hormone actions in other tissues by 
stimulating Ca 2÷ transport through the plasma 
148 





+i+~+~ +,÷i  
A~ 
÷r +1 
+, +~ +~ ~ +: +i +t +~ 
+1 +1 ~ +~ +~ 
÷i ÷i 
I + +  + + + + +  + 
~ _  ~=, .  ~ 
, , ~ = ~ ~  
~.~ ~ "~ 
• ~ ~ .~ ~ ~, ~ 
c . ~  ~, ,~ 
o - ~ 3  
~o.oE = 
. 
o,:~ ~ "6 
8~ : ~ 
°~ i °" 
~_o =o 
• ~ = o ~_~ 
,.. ~ ~ .~ ~ .~ ~, 
149 
Volume 55, number 1 FEBS LETTERS July 1975 
membrane or releasing Ca2+from intracellular stores, 
had no effect of intestinal cyclic GMP concentrations. 
Again, no significant changes of cyclic GMP were 
found in a Ca2+-containing medium in the presence 
of choleratoxin, prostaglandins, cholinergic agents, 
concanavalin A or the hormones mentioned above. 
Unexpectedly, incubation for 6-10 rain in the 
presence of the phosphodiesterase inhibitor theophyl- 
line (5 raM) with or without hormones, did not 
raise the cyclic GMP content whereas cyclic AMP was 
significantly elevated (table 2, [25]). A possible 
depression of net formation of cyclic GMP by 
cyclic-AMP-elevating a ents would not be unique 
for intestinal epithelium (compare [26]). It is 
also possible that theophylline induced a selective 
leakage of cyclic GMP to the medium where it 
may be rapidly metabolized by the residual activity 
of phosphodiesterases released from damaged cells. 
Alloxan (5 raM) strongly elevated cyclic GMP 
in the isolated cells but had no influence on cyclic 
AMP levels (table 2). Apparently, the interaction of 
alloxan with cyclases in the intact cell is opposite to 
its in vitro effect, or else alloxan possesses an additional 
inhibitory effect on intracellular cyclic nucleotide 
degradation. In either case this compound could be 
a useful tool in future studies of the relationship 
between elevated cyclic GMP levels and intestinal 
functions. 
4. Discussion 
A clear difference was found between the kinetic 
behaviour of guanylate cyclase in brushborder and 
microsomal preparations from rat small intestinal 
villous cells. Whereas the brushborder nzyme had 
many characteristics in common with the particulate 
form of guanylate cyclase from sea urchin sperm 
[27] and rat lung [8] (positive substrate co-opera- 
tivity, independency from free Mn 2÷ at saturating 
MnGTP2-concentrations), thekinetics of the micro- 
somal enzyme, mainly localized in the basal-lateral 
plasma membranes, resembled more the soluble form 
of the enzyme in rat heart [6] and lung [8] (loss of 
co-operativity, activation by free Mn 2÷ at high 
MnGTP2-1evels). Maybe the nearly complete absence 
of a soluble guanylate cyclase in rat small intestine 
is due to a high affinity of this type of enzyme for 
the basal-lateral p asma membranes. An alternative 
interpretation, assuming a rapid release of guanylate 
cyclase from membranes in other tissues during homo- 
genization, has been suggested previously [26]. Also 
an alteration of kinetic behaviour during preparation 
of the microsomes cannot be entirely excluded yet. 
The activity of the particulate guanylate cyclase 
in vitro or the levels of cyclic GMP in isolated small 
intestinal epithelial cells appeared insensitive to a 
large number of hormones or hormone-like agents 
under our experimental conditions. This insensitivity 
may be interpreted in different ways: 
1) The epithelium lacks receptors for the hormones. 
Consequently the reported hormonal effects on trans- 
port rates should be ascribed to effects on intestinal 
smooth muscle or blood vessels. 
2) Hormone ffects are mediated by factors 
different from cyclic GMP. 
3) Hormone receptors or coupling systems between 
receptors and guanylate cyclase are damaged uring 
cell isolation or homogenization. Moreover, 'permissive' 
serum factors needed for full expression of hormone 
action may be lost in the in vitro system. The deter- 
mination of cyclic GMP in samples of intestine, obtained 
by freeze-clamping the tissue in situ, would better 
reflect he physiological situation but lacks any tissue 
specificity. 
4) Cyclic GMP levels are indeed altered by some 
hormones but the changes were too small, transient 
or delayed to be measured in our experiments. Small 
effects may be expected particularly if only the 
guanylate cyclase outside the brushborder region 
responds to hormones. 
5) The reported action of cholinergic agents [24, 
26], insulin [24] and the ionophore A-23187 [28, 
29] on cyclic GMP levels in other tissues could be 
mediated by the soluble form of guanylate cyclase 
which is almost completely missing from the intestinal 
epithelium. 
To our knowledge, a hormone ffect on particulate 
guanylate cyclase is only well-established in fibro- 
blasts where cyclic GMP levels may be elevated by 
a specific growth factor, a peptide hormone secreted 
by the pituitary gland [30]. It is not known if a 
similar growth factor for proliferative crypt cells, 
regulating the guanylate cyclase activity in their 
basal-lateral p asma membranes xists. However, in 
mature villous cells, at least 70 per cent of the total 
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guanylate cyclase activity has been found in the micro- 
villous structure of the brushborder, making a direct 
coupling to hormone receptors at the antiluminal 
plasma membranes highly unlikely. [7]. Therefore, 
a possible role of cyclic GMP, generated by this 
enzyme, as a second messenger of hormone action 
must be seriously questioned. 
The universal occurrence of specific cyclic GMP- 
dependent protein kinases in rat tissues and the high 
levels of these enzymes in arthropod tissues, where 
the particulate guanylate cylase is usually very active 
[31 ], strongly suggest hat the biological effects of 
cyclic GMP are mediated by this class of proteins. 
In membranes from intestinal smooth muscle, and 
endogenous cyclic GMP-dependent protein kinase 
has been detected in association with two distinct 
substrate proteins [32]. It would be interesting 
to look for a similar system in the intestinal brush- 
border. Should the endogenous substrates be trans- 
port proteins, the slight stimulation of gunaylate 
cyclase activity in the brushborder by aminoacids 
(table 1) might be of physiological significance. 
The striking resemblance between the tubular 
structure of microvilli and flagellae [33], the 
high activity of guanylate cyclase in flagellar membranes 
from sea urchin sperm [27,34] and in platelets [35], 
and the possibility that the microfilaments within the 
core of the intestinal microvilli are actin-like [33,36], 
lend some support o the idea that cyclic GMP has 
a role in the assembly or regulation of contractile 
systems. 
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